Key facts
- This page summarizes Ronald B. Kalich Sr.'s Form 4 filing for SURMODICS INC (SRDX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Feb 2024, 16:12.
Ronald B. Kalich Sr. - 08 Feb 2024 Form 4 Insider Report for SURMODICS INC (SRDX)
- Reporting relationship
- Director
- Issuer ticker
- SRDX
- Reported as of
- 08 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Feb 2024, 16:12:46 UTC
- Prior SEC filing
- 03 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Manders, on behalf of Ronald B. Kalich
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ronald B. Kalich Sr. filed Form 4 for SURMODICS INC (SRDX) on 12 Feb 2024.
Change
- Previous filing in this sequence was filed on 03 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SRDX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +1,803
- Change %
- +4.9%
- Price
- $0.000000
- Shares after
- 38,278
- Date
- 08 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SRDX
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +3,853
- Change %
- Price
- $0.000000
- Shares after
- 3,853
- Date
- 08 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,853
- Exercise price
- $31.89
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The amount beneficially owned includes 13,900 restricted stock units (RSUs) that vest on service-based vesting dates and 14,941 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
Footnote F2
The stock options vest ratably on a monthly basis and become fully vested on February 8, 2025, the 12-month anniversary of the grant date.